Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-, . . . Bruce Strober. (2023). Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationAlexa B. Kimball, et al. Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results Up to 3 Years from the RELIEVE-AD Study. Adis, Springer Healthcare, 2023.
MLA (9th ed.) CitationAlexa B. Kimball, et al. Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results Up to 3 Years from the RELIEVE-AD Study. Adis, Springer Healthcare, 2023.
Warning: These citations may not always be 100% accurate.